Jamie Stiff
InvestorManaging Director at Genesys Capital
About
Jamie Stiff joined Genesys Capital in 2002 and became Partner in 2007, leading investments in early-stage life sciences companies and serving on numerous portfolio company boards. He previously worked in genetic diagnostics at the Samuel Lunenfeld Research Institute and holds a BSc from Queen's University and an MBA from the Rotman School of Management.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Allostera PharmaEbt MedicalEnspiredbsFairhaven PharmaceuticalsFeldan TherapeuticsgIcare PharmaGiiant Pharma Inc.Interface BiologicsInversago PharmaMatregenNaurexNeurAxonStemPathTherapeutic Monitoring SystemsVeralox Therapeutics, Inc.Zelos Therapeutics
Per the firm's website.
Colleagues at Genesys Capital
Christine Thoburn
Office Manager at Genesys Capital
Damian Lamb
Co-Founder, Managing Partner at Genesys Capital
Jennifer Williams
CFO at Genesys Capital
Kelly Holman
Co-Founder, Managing Partner at Genesys Capital
Laurie Mak
Associate at Genesys Capital
Lisa Low
Senior Vice President, Finance at Genesys Capital
Paras Sharma
Senior Associate at Genesys Capital
Sarah Farr
Senior Associate at Genesys Capital
Frequently asked questions
- Who is Jamie Stiff?
- Jamie Stiff joined Genesys Capital in 2002 and became Partner in 2007, leading investments in early-stage life sciences companies and serving on numerous portfolio company boards. He previously worked in genetic diagnostics at the Samuel Lunenfeld Research Institute and holds a BSc from Queen's University and an MBA from the Rotman School of Management.
- Where does Jamie Stiff work?
- Jamie Stiff is Managing Director at Genesys Capital.
- What does Jamie Stiff invest in?
- Jamie Stiff invests in Biotech, Healthtech, Medical Devices.
- What boards does Jamie Stiff sit on?
- Jamie Stiff holds tracked board seats at Allostera Pharma, Ebt Medical, Enspiredbs, Fairhaven Pharmaceuticals, Feldan Therapeutics, gIcare Pharma, Giiant Pharma Inc., Interface Biologics, Inversago Pharma, Matregen.